Modern features of the treatment of bacterial vaginosis in pregnant women


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Bacterial vaginosis (BV) is one of the most common diseases in pregnant women, characterized by a decrease in the number of lactobacilli and an increase in colonization by a variety of facultative and obligate anaerobes. The review article discusses the problem of BV, the mechanisms of its development, modern diagnostics and treatment tactics. The simultaneous use of antibacterial drugs and probiotics at separate times (morning and evening), with a decrease in the duration of course of therapy, and a decrease in the antibiotic burden on the body can be considered as a promising direction in the treatment of BV. The correction of the vaginal microbiota in pregnant women by the use of a probiotic containing lactic acid and glycogen deserves particular attention. The use of probiotics in pregnant women simultaneously with antibiotic therapy improves the effectiveness of treatment, has a positive effect on the course of the gestational period, and also on delivery in the future.

Full Text

Restricted Access

About the authors

N. Z Mammaeva

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Email: letuchka92@mail.ru
Moscow, Russia

I. B Manukhin

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Moscow, Russia

K. A Silaev

A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Moscow, Russia

References

  1. Muzny С.A., Lanevsky P., Schwebke J.R., Herbst Kralovets M.M.Interaction of host and vaginal microbiota in the pathogenesis of bacterial vaginosis. Curr Opin Infect Dis. 2020;32:59-65. doi: 10.1097/QCO.0000000000000620
  2. Рекомендации РОАГ. Бактериальный вагиноз. Клинические рекомендации по ведению больных бактериальным вагинозом, М., 2022. 50 с. @@Bacterial vaginosis. Clinical guidelines for the management of patients with bacterial vaginosis. M., 2022. 50 р. (In Russ.)
  3. Доброхотова Ю.Э., Боровкова Е.И., Хертек С.Е. Бактериальный вагиноз в первом триместре беременности: микробиологические и иммунологические показатели в оценке эффективности терапии. Акушерства и гинекологии. 2020:6,98-104. @@Dobrokhotova Yu.E.,Borovkova.E.I., Khertek S.E. Bacterial vaginosis in the first trimester of pregnancy:microbiological and immunological indicators in assessing the effectiveness of therapy. Akusherstvo i ginekologiya=Obstetr Gynecol. 2020:6,98-104. (In Russ.)
  4. Coudray M.S., Madhivanan P. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020;245:143-48. doi: 10.1016/j.ejogrb.2019.12.035
  5. Shaffi A.F, Balandya B, Majigo M, Aboud S. Predictors of Bacterial Vaginosis among Pregnant Women Attending Antenatal Clinic at Tertiary Care Hospital in Tanzania: A Cross Sectional Study. East Afr Health Res J. 2021;5(1):59-68. doi: 10.24248/eahrj.v5i1.652.
  6. Vodstrcil L.A., Muzny C.A, Plummer E.L. Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment. BMC Med. 2021;19(1):194. doi: 10.1186/s12916-021-02077-3.
  7. Sule-Odu A.O., Oluwole A.A, Akadri A.A. Bacterial vaginosis in pregnancy and early labour using Nugent scoring and the implication on foetal outcome. Ghana Med J. 2020;54(1):10-6. doi: 10.4314/gmj.v54i1.3.
  8. Wang W, Hao J., An R. Abnormal vaginal flora correlates with pregnancy outcomes: A retrospective study from 737 pregnant women.Eur J Obstet Gynecol Reprod Biol. 2022;272:64- 68. doi: 10.1016/j.ejogrb.2022.03.013.
  9. Shimaoka M., Yo Y., Doh K. Association between preterm delivery and bacterial vaginosis with or without treatment. Scientific Reports. 2019;9(1):509. doi: 10.1038/s41598-018-36964-2.
  10. Zwittink R.D., van den Munckhof E.H.A., Leverstein-van Hall M.A. The vaginal microbiota in the course of bacterial vaginosis treatment. Eur J Clin Microbiol Infect Dis. 2021;40(3):651-56. doi: 10.1007/s10096-020-04049-6.
  11. Chen X., Lu Y., Chen T. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021;11. doi: 10.3389/fcimb.2021.631972.
  12. Muzny C.A., Taylor C.M., Swords W.E., et al. An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis. J Infect Dis. 2019;220(9):1399-405. doi: 10.1093/infdis/ jiz342.
  13. Coleman J.S., Gaydos C.A. Molecular Diagnosis of Bacterial Vaginosis: an Update. Am Soc Microbiol. 2018;56(9). doi: 10.1128/JCM.00342-18.
  14. Redelinghuys M.J., Geldenhuys J., Hyunsul Jung. Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities. Front Cell Infect Microbiol. 2020;10:354. Doi: 10.3389/ fcimb.2020.00354.
  15. Foessleitner P., Kiss H., Deinsberger J. Screening Pregnant for women Bacterial Vaginosis Using a Point-of-Care Test: A Prospective Validation Study. J Clin Med. 2021;10(11):2275. Doi: 10.3390/ jcm10112275.
  16. Toboso Silgo L., Cruz-Melguizo S., de la Cruz Conty M.L., et al. Screening for Vaginal and Endocervical Infections in the First Trimester of Pregnancy? A Study That Ignites an Old Debate. Pathogens. 2021;10(12):1610. Doi: 10.3390/ pathogens10121610.
  17. Chacra L.A., Fenollar F, Khoudia Diop. Bacterial Vaginosis: What Do We Currently Know? Front Cell Infect Microbiol. 2022;18;11:672429. doi: 10.3389/fcimb.2021.672429.
  18. Muzny C.A, Przemyslaw K. A Narrative Review of Current Challenges in the Diagnosis and Management of Bacterial Vaginosis. Sex Transm Dis. 2020;47(7):441-46. Doi: 10.1097/ 0LQ.0000000000001 178.
  19. Sobel J.D. Bacterial vaginosis: Treatment. 2022.
  20. Brocklehurst P., Gordon A., Heatley E., Milan S.J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013;(1):CD000262. doi: 10.1002/14651858. CD000262.
  21. Yudin M.H., Money D.M. No. 211-Screening and Management of Bacterial Vaginosis in Pregnancy. J Obstet Gynaecol Can. 2017;39(8):e184-e191. doi: 10.1016/j.jogc.2017.04.018.
  22. Клинические рекомендации РОАГ Клинические рекомендации по диагностике и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей. 2015. 59 с. @@Clinical recommendations of the ROAG. Clinical recommendations for the diagnosis and treatment of diseases accompanied by pathological discharge from the genital tract. 2015. 59p. (In Russ.).
  23. Сгибнев А.В., Кремлева Е.А. Потенцирование активности антибиотиков метаболитами нормальной вагинальной микрофлоры. Акушерство и гинекология. 2017;3:14-20. @@Sgibnev A.V., Kremlyova E.A. Potentiation of antibiotic activity by metabolites of normal vaginal microflora. Akusherstvo i ginekologiya=Obstetr Gynecol. 2017;3:14-20. (In Russ.). doi: 10.18565/aig.2017.3.108-14.
  24. Кира Е.Ф Пробиотики в восстановлении микробиоценоза влагалища. Акушерство и гинекология. 2017;5:32-8. @@Kira E.F., Probiotics in the restoration of vaginal microbiocenosis. Akusherstvo i ginekologiya Obstetr Gynecol. 2017;5:32-8. (In Russ.). doi: 10.18565/aig.2017.5.32-8.
  25. Сгибнев А.В., Кремлева Е.А, Щетина Ю.С. Совместное применение антимикробных и пробиотических препаратов как способ повышения эффективности терапии генитальных инфекций. Акушерство и гинекология. 2018;4:112-17. [Sgibnev A.V, Kremlyova E.A., Shchetina Yu.S. The combined use of antimicrobial and probiotic drugs as a way to increase the effectiveness of therapy for genital infections. Akusherstvo i ginekologiya=Obstetr Gynecol. 2018;4:112-17. (In Russ)]. Doi: 10.18565/ aig.2018.4.113-118.
  26. Wang Z., He Y, Zheng Y. Probiotics for the Treatment of Bacterial Vaginosis: A Meta-Analysis.Int J Environ Res Public Health. 2019;16(20):3859. doi: 10.3390/ijerph16203859.
  27. Яремчук Т.П. Оценка эффективности пробиотика Неопробио в восстановлении нарушенного микробиома влагалища беременных. Репродуктивное здоровье. Восточная Европа. 2018;8(6):786-94. @@Yaremchuk T.P. Evaluation of the effectiveness of the probiotic Neoprobio in restoring the disturbed microbiome of the vagina of pregnant women. Reproduktivnoe zdorov'e. Vostochnaya Evropa. 2018;8(6):786-94. (In Russ.).
  28. Тапильская Н.И., Савичева А.М., Шипицына Е.В. Применение препарата Лактожиналь для коррекции нарушения микробиоценоза влагалища у беременной с наложенным швом на шейку матки: клинический случай и обзор литературы. Журнал акушерства и женских болезней. 2016;6:90-5. @@Tapilskaya N.I., Savicheva A.M., Shipitsyna E.V The use of the drug Lactoginal for the correction of a violation of the microbiocenosis of the vagina in a pregnant woman with a suture on the cervix: clinical case and literature review. Zhurnal akusherstva i zhenskikh boleznei. 2016;6:90-5. (In Russ). doi: 10.17816/JOWD65689-95.
  29. Amabebe E., Anumba D.O.C. The Vaginal Microenvironment: The Physiologic Role of Lactobacilli. Front Med. (Lausanne). 2018;181:13. doi: 10.1093/infdis/jiz342.
  30. Bagnall P., Rizzolo D. Bacterial vaginosis: A practical re view. JAAPA. 2017;30(12):15-doi: 10.1097/01.JAA.0000526770.60197.fa.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies